Jennifer Ebner von Eschenbach

  • "Investing that little extra time and effort in IP at the right moment makes your technology go further"
    • Biography

    • Jennifer Ebner von Eschenbach began her career as a European patent attorney in 1991 when she commenced her training in the Munich office of the international IP law firm of Ladas & Parry, LLP. Jennifer took over the office management from 1996-2008, during which time she was involved with the prosecution of patent applications for many multinational companies and research institutions. This provided her with an insight of IP needs covering a broad technological spectrum.

      Since joining V.O. in 2008, Jennifer has focused on developments in the pharmaceutical and chemical sectors, including novel therapies, diagnostic tools, (bio)technological processes for the employment of renewable resources, as well as environmentally-conscious chemical processes/products, again spanning both a broad range of technologies and clients. Jennifer has a wide practical experience in procuring and defending patents, including the filing and defense of oppositions. Through the provision of opinions on patent validity and infringement, she also has considerable experience in advising on parties’ freedom to operate.

    • Working experience

    • Patent Attorney, V.O. (2008-present)
    • Patent Attorney, Ladas & Parry, LLP (1991-2008): Manager of office in Munich (1996-2008)
    • Post-Doctoral Research, Inorganic Chemical Institute of the Technical University of Munich (1989-1990)
    • Education

    • PhD in Chemistry, University of Melbourne (1988)
    • MSc in Chemistry, University of Melbourne (1984, with honours)
    • Qualifications

    • European Patent Attorney
    • Specializations

    • Agrochemistry
    • Biochemistry
    • Biology
    • Biomedical technology
    • Biophysics
    • Biotechnology
    • Chemical technology
    • Chemistry
    • Foods
    • Health products
    • Inorganic chemistry / materials science
    • Life Science
    • Materials science
    • Medical diagnostics
    • Medical sciences
    • Medicine
    • Medicines
    • Microbiology
    • Nanotechnology
    • Organic chemistry
    • Packaging
    • Pharmaceuticals
    • Photochemistry
    • Physical chemistry
    • Polymer chemistry
    • Process technology
    • Semiconductors
    • Spectroscopy
    • Supplementary protection certificates (SPC)
    • Vaccines
    • Water
    • Publications

    • Schmidbaur H., Ebner von Eschenbach J., Kumberger O., & Müller G., Cyclic Dinuclear Gold(I) Complexes: The Crystal Structure of Bis-µ-[(diphenylphosphino)(diphenylphosphinoselenoyl)methane]-digold(I) Bis(perchlorate), Chem. Ber., 123, 2261-2265, 1990
    • Bond A. M., Colton R., Ebner J., & Ellis S. R., Differences in Nature and Stability of Cadmium Complexes with Group 15/Group 16 Donor Ligands as Determined by Multinuclear (31P, 77Se, 113Cd) Magnetic Resonance and Electrochemical Techniques, Inorganic Chemistry, 28, 4509-4516, 1989
    • Colton R., Ebner J., & Hoskins B. F., Multinuclear Magnetic Resonance Studies of the Reactions of Bidentate Ligands with Pt(S2P{OEt}2)2. Crystal and Molecular Structure of (apeS)Pt(S2P{OEt}2)2 (ApeS = Ph2AsCH2CH2P(S)Ph2) , Inorganic Chemistry, 27, 1993-1999, 1988
    • Bond A. M., Colton R., & Ebner J., Multinuclear Magnetic Resonance (31P, 77Se, 199Hg) and Electrochemical Studies of Non-labile Mercury(II) Complexes with Group 15/Group 16 Donor Ligands, Inorganic Chemistry, 27, 1697-1702, 1988
    • Latest thinking

    • Forum Life Science, 8th International Congress and Exhibition, Technical University of Munich, Germa
    • MedTech Pharma, Congress and Exhibition, Nürnberg, Germany, July 2012
    • Languages

    • German
    • English